Astera Labs, Inc. $ALAB Position Decreased by Vontobel Holding Ltd.

Key Points

• Vontobel Holding cut its Astera Labs stake by 47.7% in the third quarter, selling 5,632 shares and retaining 6,176 shares valued at approximately $2.2 million.
• Institutional investors own 60.47% of Astera Labs, while analysts maintain a “Moderate Buy” consensus with an average price target of $348.33; ratings include 11 Buys and 10 Holds.
• Astera Labs reported quarterly EPS of $0.80 versus the $0.69 consensus and revenue of $392.4 million, up 104.5% year over year. Insiders sold 408,558 shares worth $127.3 million over the past three months.

Vontobel Holding Ltd. decreased its stake in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 47.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,176 shares of the company's stock after selling 5,632 shares during the period. Vontobel Holding Ltd.'s holdings in Astera Labs were worth $2,198,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in ALAB. BlackRock Inc. purchased a new stake in shares of Astera Labs in the 2nd quarter valued at $6,609,581,000. Atreides Management LP increased its holdings in shares of Astera Labs by 108.9% in the first quarter. Atreides Management LP now owns 3,365,787 shares of the company's stock worth $368,890,000 after buying an additional 1,754,593 shares during the period. Van ECK Associates Corp boosted its holdings in Astera Labs by 20.0% during the 2nd quarter. Van ECK Associates Corp now owns 2,237,961 shares of the company's stock valued at $1,080,980,000 after acquiring an additional 373,545 shares during the period. Bank of America Corp DE bought a new position in Astera Labs during the 2nd quarter worth approximately $1,061,791,000. Finally, Amundi raised its holdings in Astera Labs by 77.9% during the 1st quarter. Amundi now owns 1,880,830 shares of the company's stock valued at $206,139,000 after buying an additional 823,477 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company's stock.

Analyst Ratings Changes

A number of analysts have recently weighed in on ALAB shares. Morgan Stanley increased their target price on shares of Astera Labs to $335.00 and gave the stock an "overweight" rating in a report on Monday, August 3rd. Roth Capital restated a "buy" rating and issued a $450.00 price objective on shares of Astera Labs in a report on Wednesday, August 5th. Citigroup downgraded shares of Astera Labs from a "buy" rating to a "hold" rating in a research note on Friday, October 9th. Barclays lifted their price objective on Astera Labs from $200.00 to $325.00 and gave the company an "equal weight" rating in a research report on Monday, July 20th. Finally, Stifel Nicolaus increased their price objective on Astera Labs from $260.00 to $460.00 and gave the stock a "buy" rating in a report on Wednesday, June 24th. Eleven analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $348.33.

Insider Buying and Selling at Astera Labs

In other news, Director Manuel Alba sold 183,000 shares of the business's stock in a transaction on Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total value of $51,263,790.00. Following the transaction, the director owned 253,863 shares of the company's stock, valued at approximately $71,114,642.19. The trade was a 41.89% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of the firm's stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief executive officer owned 1,266,665 shares of the company's stock, valued at approximately $431,109,432.75. The trade was a 6.68% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders have sold 408,558 shares of company stock valued at $127,306,034. 10.40% of the stock is currently owned by company insiders.

Astera Labs Stock Performance

Astera Labs stock opened at $285.82 on Monday. Astera Labs, Inc. has a one year low of $97.89 and a one year high of $499.48. The stock has a fifty day moving average of $314.86 and a 200 day moving average of $298.39. The stock has a market cap of $49.59 billion, a PE ratio of 141.50 and a beta of 3.68.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. During the same period in the previous year, the business posted $0.44 earnings per share. The firm's quarterly revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, sell-side analysts predict that Astera Labs, Inc. will post 2.70 EPS for the current fiscal year.

Astera Labs Company Profile

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company's portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.